Counterpoint Mutual Funds LLC lifted its position in Counterpoint Quantitative Equity ETF (NYSEARCA:CPAI – Free Report) by 5.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,549,616 shares of the company’s stock after buying an additional 78,500 shares during the quarter. Counterpoint Quantitative Equity ETF makes up 9.7% of Counterpoint Mutual Funds LLC’s investment portfolio, making the stock its 2nd largest holding. Counterpoint Mutual Funds LLC owned approximately 0.28% of Counterpoint Quantitative Equity ETF worth $64,758,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of CPAI. JPMorgan Chase & Co. lifted its stake in Counterpoint Quantitative Equity ETF by 4.9% during the 2nd quarter. JPMorgan Chase & Co. now owns 6,130 shares of the company’s stock worth $228,000 after acquiring an additional 286 shares in the last quarter. Raymond James Financial Inc. acquired a new position in Counterpoint Quantitative Equity ETF in the 2nd quarter valued at about $1,121,000. Susquehanna International Group LLP purchased a new stake in Counterpoint Quantitative Equity ETF during the third quarter worth about $850,000. NewEdge Advisors LLC increased its stake in Counterpoint Quantitative Equity ETF by 42,796.4% during the third quarter. NewEdge Advisors LLC now owns 23,593 shares of the company’s stock worth $932,000 after purchasing an additional 23,538 shares during the period. Finally, Sunbelt Securities Inc. purchased a new stake in Counterpoint Quantitative Equity ETF during the third quarter worth about $366,000.
Counterpoint Quantitative Equity ETF Stock Performance
Shares of CPAI opened at $51.01 on Friday. The company’s 50-day simple moving average is $49.27 and its 200-day simple moving average is $45.12. Counterpoint Quantitative Equity ETF has a 1 year low of $35.06 and a 1 year high of $52.30. The stock has a market capitalization of $362.17 million, a PE ratio of -61,163.07 and a beta of 1.17.
Counterpoint Quantitative Equity ETF Company Profile
The Counterpoint Quantitative Equity ETF (CPAI) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, seeking long-term capital appreciation through a quantitative, model-based approach to select US stocks of any market capitalization. CPAI was launched on Nov 28, 2023 and is issued by Counterpoint.
Featured Stories
- Five stocks we like better than Counterpoint Quantitative Equity ETF
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Want to see what other hedge funds are holding CPAI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Counterpoint Quantitative Equity ETF (NYSEARCA:CPAI – Free Report).
Receive News & Ratings for Counterpoint Quantitative Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Counterpoint Quantitative Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.
